ArticlePloS one2012
Disease-free survival after hepatic resection in hepatocellular carcinoma patients: a prediction approach using artificial neural network.
Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Machine learning to guide clinical decision-making in abdominal surgery-a systematic literature review.Langenbeck's archives of surgery · 2022Pooled it
- Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review.World journal of gastroenterology · 2020Pooled it
- Perioperative allogenenic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis.PloS one · 2013Pooled it
- Factor Analysis of the Effect of Hepatitis B-Related Liver Cancer Treatment Efficacy.Journal of hepatocellular carcinoma · 2025Article
- Artificial Intelligence in Perioperative Planning and Management of Liver Resection.Indian journal of surgical oncology · 2024Review
- Risk Factors and Nomogram Model for Hepatocellular Carcinoma Development in Chronic Hepatitis B Patients with Low-Level Viremia.International journal of medical sciences · 2024Article
- Prognosis of COVID-19 patients using lab tests: A data mining approach.Health science reports · 2023Article
- The Role of Radiomics and AI Technologies in the Segmentation, Detection, and Management of Hepatocellular Carcinoma.Cancers · 2022Review
- Role of three-dimensional printing and artificial intelligence in the management of hepatocellular carcinoma: Challenges and opportunities.World journal of gastrointestinal oncology · 2022Review
- Phase Attention Model for Prediction of Early Recurrence of Hepatocellular Carcinoma With Multi-Phase CT Images and Clinical Data.Frontiers in radiology · 2022Article
- Challenges and opportunities in the application of artificial intelligence in gastroenterology and hepatology.World journal of gastroenterology · 2021Review
- Current updates in machine learning in the prediction of therapeutic outcome of hepatocellular carcinoma: what should we know?Insights into imaging · 2021Review
- Predicting early refractoriness of transarterial chemoembolization in patients with hepatocellular carcinoma using a random forest algorithm: A pilot study.Journal of Cancer · 2021Article
- Application of artificial intelligence in the diagnosis and treatment of hepatocellular carcinoma: A review.World journal of gastroenterology · 2020Review
- The Korea Cancer Big Data Platform (K-CBP) for Cancer Research.International journal of environmental research and public health · 2019Article
- Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning.Journal of cellular and molecular medicine · 2019Article
- Risk prediction model of dyslipidaemia over a 5-year period based on the Taiwan MJ health check-up longitudinal database.Lipids in health and disease · 2018Article
- Comparing Three Data Mining Algorithms for Identifying the Associated Risk Factors of Type 2 DiabetesIranian biomedical journal · 2018Article
- Application of multiplex methylated-specific PCR with capillary electrophoresis to explore prognostic value of TSGs hypermethylation for hepatocellular carcinoma.Journal of clinical laboratory analysis · 2018Article
- Evaluation of Osteopontin as a Biomarker in Hepatocellular Carcinomas in Egyptian Patients with Chronic HCV CirrhosisAsian Pacific journal of cancer prevention : APJCP · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA database for hepatocellular carcinoma (HCC) patients who had received hepatic resection was used to develop prediction models for 1-, 3- and 5-year disease-free survival based on a set of clinical parameters for this patient group.
methodsThe three prediction models included an artificial neural network (ANN) model, a logistic regression (LR) model, and a decision tree (DT) model. Data for 427, 354 and 297 HCC patients with histories of 1-, 3- and 5-year disease-free survival after hepatic resection, respectively, were extracted from the HCC patient database. From each of the three groups, 80% of the cases (342, 283 and 238 cases of 1-, 3- and 5-year disease-free survival, respectively) were selected to provide training data for the prediction models. The remaining 20% of cases in each group (85, 71 and 59 cases in the three respective groups) were assigned to validation groups for performance comparisons of the three models. Area under receiver operating characteristics curve (AUROC) was used as the performance index for evaluating the three models.
conclusionsThe ANN model outperformed the LR and DT models in terms of prediction accuracy. This study demonstrated the feasibility of using ANNs in medical decision support systems for predicting disease-free survival based on clinical databases in HCC patients who have received hepatic resection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.